Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MRGPRX2 | Q96LB1 | 1/20 | 0.42 |
| ▸ | ACACB | O00763 | 17/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | FFAR2 | O15552 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27211370 | 1.00 | MRGPRX2 (0.42) | MRGPRX2ACACBTDP1FFAR2 | |
| SCHEMBL24297738 | 0.85 | MRGPRX2 (0.55) | MRGPRX2ACACB | |
| SCHEMBL29078026 | 0.85 | MRGPRX2 (0.55) | MRGPRX2ACACB | |
| SCHEMBL30473701 | 0.85 | MRGPRX2 (0.55) | MRGPRX2ACACB | |
| SCHEMBL31133294 | 0.85 | MRGPRX2 (0.55) | MRGPRX2ACACB | |
| SCHEMBL27211481 | 0.84 | FFAR2 (0.39) | ACACBTDP1FFAR2 | |
| SCHEMBL31132457 | 0.83 | MRGPRX2 (0.43) | MRGPRX2ACACBTDP1 | |
| SCHEMBL27211501 | 0.83 | MRGPRX2 (0.43) | MRGPRX2ACACBTDP1 | |
| SCHEMBL29563814 | 0.83 | MRGPRX2 (0.43) | MRGPRX2ACACBTDP1 | |
| SCHEMBL31132482 | 0.81 | CARM1 (0.43) | MRGPRX2ACACBTDP1FFAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11976057-B2 | MrgX2 antagonists | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2024-05-07 | — | — | US | disclosed |
| US-20220112174-A1 | MRGX2 ANTAGONISTS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2022-04-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11976057-B2 | MrgX2 antagonists | MRGPRX2, MRGPRX1, MRGPRX4 | MRGPRX2 1/4885ACACB 4342/4885TDP1 4070/4885 |
| US-20220112174-A1 | MRGX2 ANTAGONISTS | MRGPRX2, MRGPRX1, MRGPRX4 | MRGPRX2 1/4885ACACB 4342/4885TDP1 4070/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.